author-photo

Z. Mitri

3

Papers

3

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

265P Study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in combination with fulvestrant in patients with advanced hormone receptor positive HER2 negative breast cancer (HR+BC)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
An Integrated Clinical, Omic, and Image Atlas of an Evolving Metastatic Breast Cancer

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (3)
Abstract P6-18-25: First-line treatment with ribociclib and letrozole in advanced breast cancer: First interim data from US patients enrolled in the phase 3b CompLEEment-1 clinical trial

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)